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Background: Acute respiratory tract infections are the common causes for admission to emergency department.
Appropriate diagnosis and initiating treatment on time are important for reducing morbidity and mortality rate due
to lower respiratory tract infection (LRTI). The aim of this study is to determine if C-reactive protein (CRP) levels and
white blood cells (WBC) count are considerable markers to help rapid diagnosis and prediction of antibiotic need
for lower respiratory infections in emergency departments. The relationships between infectious agents and those
markers have also been evaluated.
Methods: Study subjects and control group were selected by defined criteria. Patients were analyzed and assessed
for CRP and WBC, sputum Gram stain and culture besides routine laboratory tests and chest X-Rays.
Results: One hundred and ninety four episodes out of 175 patients were evaluated for the study. CRP level and
WBC count were detected significantly higher in patients ofstudy group than in those of control group.
Pseudomonas aeruginosa and Haemophilus influenzae were the pathogens most often isolated.
Conclusion: In conclusion, CRP and WBC sputum are important markers for diagnosis of LRTI at the emergency
departments and results of microbiological analysis of respiratory specimens were correlated with these markers.
Trial registration: Registation number of ethic committee of Dr. Suat Seren Chest Diseases and Surgery Training
and Research Hospital: 28.04.2006/114
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Respiratory tract infections are among the most com-
mon reasons for admission to emergency departments
(ED) [1]. Although antibiotic treatment is considered ne-
cessary only for community-acquired pneumonia and
small subgroups of the other lower and upper respira-
tory tract infections, antibiotics are prescribed to about
80% of patients consulting for lower respiratory tract in-
fection (LRTI) [2]. Signs and symptoms are of limited
value in identifying those patients who need antibiotic
treatment [1]. Diagnostic uncertainty and patient-related
factors, such as patient expectations and pressure, often
lead to unjustified antibiotic prescriptions by emergency
physicians [3].
LRTI mainly include bronchitis, bronchiolitis and pneu-
monia [4]. Acute exacerbations of chronic obstructive* Correspondence: drshenol@yahoo.com
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reproduction in any medium, provided the orpulmonary disease (AE-COPD) and pneumonia often
cause LRTIs in ED visits [5]. Emergency departments are
required to diagnose and manage patients with severe
pneumonia associated with a high morbidity and mortality
and antibiotic timing is accepted as a measure of hospital
quality [6,7].
COPD was detected in 23% of respiratory diseases and
caused mortality in 3.3% of all hospitalizations in Turkey
[8]. In developed countries, it is the fourth leading cause
of death with 4.3%; but it is the second with 10.8% rate
in developing countries [9].
The Gram stain method is one of the most commonly
used technique for the rapid diagnosis of bacterial infec-
tions. The result of the Gram stain can be reported in
less than 10 minutes, giving the physician a reasonable
idea of its identity upon which to base treatment. Gram
staining provides a presumptive diagnosis and some in-
dication of the organism involved without waiting for
culture results. The specimen is obtained by deep cough
and should be grossly purulent. Culture should bed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and















Figure 1 Flowchart of the selection method of study and control groups.
Table 1 Demographic data of the patients and controls
n Gender Age Smoking
% Package/year
AECOPD 115 109 M, 6 F 64.4 ±11.4 94% 52.7 ± 24.7
PNEUMONIA 64 55 M, 9 F 64.3 ± 12.4 74% 51.6 ± 26.0
*OTHERS 15 10 M, 5 F 68.3 ± 9.6 66% 54.5 ± 25.2
TOTAL CASES 194 174 M, 20 F 64.2 ± 11.7 92% 52.5 ± 25.6
CONTROLS 50 31 M, 19 F 46.2 ± 17.4 42% 20.5 ± 8.5
* Asthma n = 3, interstitial pulmonary diseases n = 2, acute bronchitis,
tracheitis, silicosis, operated esophageal carcinoma.
F, Female, M, Male.
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criteria (except for detection of legionella or mycobac-
teria). Controversy surrounds the role of Gram stain and
culture analysis of expectorated sputum in patients with
community-acquired pneumonia. Most reports suggest
that these tests have poor positive and negative predict-
ive value in LRTI patients [10]. However, these tests
should be performed to try to identify etiologic organ-
isms in the hope of reducing microbial resistance to
drugs, unnecessary drug costs, and avoidable side effects
of empirical antibiotic therapy [11].
In Turkey, according to national statistics, 14.8% of
all hospitalizations are due to respiratory disease
other than tuberculosis. Lower respiratory infections
except tuberculosis are the cause of the whole mor-
tality in 4.1% percentage. Respiratory diseases and re-
spiratory infections are reported 13.8% and 3.3% rate,
respectively [12].
The aim of this study is to determine etiological bac-
terial agents and the possible inflammatory markers in
patients with or without adequate respiratory secretions
who presented to the ED of one hospital with symptoms
of respiratory infection.Methods
The study was planned as a prospective, open observa-
tional study in ED of a tertiary referral center for chest
diseases and chest surgery.
Patients who met the inclusion criteria in 2006 were
enrolled in the study.
Inclusion criteria:
1. Acute illness present for 14 days or less;
2. At least one lower respiratory tract symptom (cough,
sputum production, dyspnea, wheezing, chest pain);
Table 2 Symptoms of the patients
N SYMPTOMS
n (%)
Dyspnea Cough Expectoration Fever Chest pain Hemoptysis
AECOPD 115 115 (100) 65 (56.5) 52 (45.2) 1 (0.9) 1 (0.9) 2 (1.7)
PNEUMONIA 64 59 (92.1) 44 (68.7) 37 (57.8) 15 (23.4) 2 (3.1) 5 (7.8)
OTHERS 15 13 (86.6) 7 (46.6) 4 (26.6) 1 (6.6) 0 3 (20)
Table 3 Laboratory findings of study subjects and controls
N CRP WBC
AECOPD 115 9.8 + 9.9 12640 + 4800
PNEUMONIA 64 11.2 + 8.9 14490 +6400
OTHERS 15 14.0 + 12.5 13100 + 6200
CONTROLS 50 3,5 ± 1.9 8100 ± 3100
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sinusitis, pharyngitis, or a new presentation of asthma.
4. And/or fever.
Exclusion criteria
Confirmed tuberculosis cases were excluded from the
study. Patients affected with cardiovascular diseases,
thromboembolism, pregnancy, those who used cortico-
steroids within the last six months, and those who had
been discharged from hospital within seven days before
were not included.
Control cases were randomly selected from patients
with respiratory complaints, retrospectively.
Diagnosis of COPD was confirmed by spirometry after
acute exacerbation in patients at their first admission to
the hospital. Pneumonia was diagnosed by infiltration on
chest X-Ray in addition of inclusion criteria. Flow chart
of the selection method is shown in Figure 1.
Microbiology
Bacteriological sputum cultures, WBC count and CRP test
were performed for all cases besides other conventional
tests according to the nature of cases on the day of admis-
sion. Sputum samples were sent to the bacteriology div-
ision. They were previously examined macroscopically for
evaluating the qualification for culture by laboratory techni-
cian. Samples which included saliva or food within insuffi-
cient respiratory secretions were rejected. Sputum samples
were analyzed by Gram stains and culture methods. Spu-
tum purulence was identified as above 25 polymorpho-
nuclear leucocytes (PNL) per low power microscopic field
[11]. Identification of micro-organisms was done by con-
ventional microbiological methods and semi-automated
systems (Crystal, BD, Maryland, USA). Antibiotic suscepti-
bility of bacteria was done by disc diffusion method accor-
ding to CLSI recommendations. CRP and WBC were
studied in serology division of microbiology laboratory.
CRP levels were tested by nephelometric method. (Array
360 System, Beckman Coulter, USA). WBC was counted by
Coulter hematology analyzer (Beckman Coulter, USA).
SPSS 15 program was used for statistical analysis. Dis-
tribution of data was evaluated by Kolmogorov Smirnov
test. Analysis of parametric variables was performed with
t test; Kruskal Wallis and Mann-Whitney tests were ap-
plied for nonparametric distributed variables. Chi-squaretest was used for analyzing categorical data. p under 0.05
was accepted as significant.
This research was carried out in compliance with the
Helsinki Declaration, and approved by ethic committee
of Dr. Suat Seren Chest Diseases and Surgery Training
and Research Hospital, İzmir, Turkey with 28.04.2006/
114 registration number.
Results
In the study period, 31,257 episodes of 21,346 patients
were examined and 2,298 cases of pneumonia and other
lower respiratory infections were detected in 1,480 in
patients in ED.
The cases which met the inclusion criteria (194 episodes
of 175 patients) and 50 controls were studied. The patho-
logical conditions of control patients were twenty one
common cold, ten pharyngitis, eight asthma, four pneu-
mothorax, two thoracic injury, two foreign body aspiration,
one corpulmonare, one acute laryngitis and one sinusitis.
Table 1 shows demographic data of the cases and
controls.
Prevalence of smoking and pack/year were found sig-
nificantly higher in the LRTI group than in controls.
Symptoms and laboratory findings of the patients are
reported in Tables 2 and 3, respectively. Shortness of
breath was the major symptom in all patients in the LRTI
group. Fever was seen in higher rate in pneumonia cases
than in other cases. Comparative values of CRP and WBC
in cases and controls are shown in Figure 2a and 2b. CRP
and WBC values were significantly higher in LRTI subjects
than in controls (p < 0.001). Differential leukocyte count
indicated normal or neutrophilic increase in patients.
In Figure 3, microbiological analysis of sputum sam-
ples are shown. WBC and CRP levels according to mi-
croscopic features of sputum are detailed in Table 4. The
results showed that when pathogen isolation was not
possible, CRP was an important marker for diagnosis
Figure 2 a. WBC values of study and control cases. b. CRP values of study and control cases.
Figure 3 Bacterial agents isolated in sputum samples according
to study groups.
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influenzae were the most frequent pathogens.
Mean number of previous hospital admissions was sig-
nificantly higher in P. aeruginosa infections (p = 0.142).
In infections due to other agents, the numbers of previ-
ous admissions did not show significant difference.
Discussion
We have reported in this study serum CRP responses,
WBC count and sputum purulence in patients with
lower respiratory infections according to data obtained
from a population-based study that includes all spectra
of the disease together with strict criteria for unequivo-
cal diagnosis. The present results provide evidence for
the usefulness of the CRP assay, WBC count and spu-
tum microbiology in the diagnosis of LRTI in ED and to
evaluate the need for antibiotic therapy.
CRP is an acute-phase protein with levels quickly rising
during inflammatory processes [2]. Relationship between
CRP and infection of the lower respiratory tract was indi-
cated by different studies in literature. High CRP levels were
reported sensitive and specific to determine lower respira-
tory diseases [13]. Almirres et al. reported that CRP levels
have been shown to be also useful in confirming the diagno-
sis, since they were significantly higher in patients with true
pneumonia than in those in whom the diagnosis was not
confirmed at follow up [14]. Macfarlane et al. in a study of
lower respiratory tract infections in patients attending an
outpatient setting, reported that 65% of patients with radio-
graphically confirmed disease showed high serum CRP
levels (above 5 mg/dL) compared with 40% in those
with radiographic findings that were consistent with
infection, and 11% in those who had no changes consistent
with infection [1]. Melbye et al. showed that serum CRP
level of above 5 mg/dL in patients with symptoms of re-
spiratory infection who had been treated as outpatients hada sensitivity of 54% and a specificity of 95% for the diagnosis
of pneumonia [15]. In a study by Castro-Guardiola et al. on
cases of pneumonia diagnosed at the hospital ED, mean
serum CRP levels of 18.1 mg/dL were found in cases of con-
firmed pneumonia and much lower titers in false-positive
cases [16]. Gomperts et al. showed that purulent exacerba-
tions were associated with significant bronchial and systemic
inflammation and positive bacterial cultures. CRP values
were reported significantly high in the purulent bronchitis
[17]. A CRP test result adds incremental information to the
physicians’ information obtained from medical history and
physical examination [18]. The introduction of CRP testing
to assist antibiotic prescribing decisions in LRTI resulted in
a reduction of antibiotic use [2].
High WBC count was found associated with AECOPD
as well as with pneumonia in literature. Sin et al.
pointed out that blood WBC were elevated in a directly
Table 4 WBC and CRP levels according to microscopic features of sputum
>5 mg/dl 0.8-5 mg/dl <0.8 mg/dl WBC >10000/ml
n (mean ± SD)
Microscopy* of sputum samples >25 PNL 20 (17,7 ± 12,3) 7 (2,4 ± 1,1) 1 (0,3 ± 0) 19 (12275 ± 5300)
10-25 PNL 10 (13,2 ± 7,2) 2 (2,8 ± 0,4) 0 8 (15680 ± 8390)
<10 PNL 14 (18,8 ± 16,7) 5 (2,9 + 0,9) 8 (0,3 ± 0,2) 19 (13640 + 6000)
No expectoration 2 (29,2 ± 16,4) 6 (2,9 ± 1,2) 3 (0,5 ± 0,4) 5 (9950 ± 4440)
*per low power field (×10).
Tatar et al. Multidisciplinary Respiratory Medicine 2013, 8:20 Page 5 of 6
http://www.mrmjournal.com/content/8/1/20proportional manner with severity of exacerbation [19].
Gan et al. also reported high WBC in AECOPD with
has been showing with increased systemic inflammation
that reflected the severity of exacerbation [20]. Roche
et al. concluded that leukocyte count would be remark-
able in patients hospitalized for COPD exacerbations
with purulent sputum [21]. Besides, some studies dis-
agreed that WBC elevates in COPD, because it was
found a normal WBC count and markedly elevated CRP
level in AECOPD [13,22]. Thus, it has been suggested
that it is reasonable to check CRP level in addition to
WBC count in patients admitted the ED due to fever.
Performing microbiological research as early as during
ED admission could help a definitive diagnosis. Atasever
et al. suggested that sputum samples, which were col-
lected from patients at the moment they applied to ED,
are important for isolation of etiologic agents of lower
respiratory infections. They also reported that high CRP
level and high WBC count were found significant in
diagnosis of respiratory infections. They concluded that
results would help when deciding if antibiotics should
initially be used to treat patients with AECOPD [23].
On the other hand, van der Meer reported in his review
that testing for CRP is not sufficiently sensitive and spe-
cific to rule out an infiltrate on chest radiograph and bac-
terial etiology of LRTIs. He concluded that the evidence
was not sufficient to support a wide introduction of CRP
as a rapid test to guide antibiotics prescription [24].
Additionally we found that isolation of P. aeruginosa was
getting higher along with high number of previous admis-
sions. Russel et al. reported that a quarter of potentially
pathogenic microorganisms colonize the patients with
COPD during their stable periods. Exacerbation is associ-
ated with the overgrowth of these microorganisms and
with the appearance of P. aeruginosa in the lower airway,
which is associated with exacerbation symptoms independ-
ent of load [25]. Ohmagari et al proposed that extended
spectrum antibiotics may need to be used as first-line em-
pirical therapy for COPD with prior infection that requires
hospitalization, and as alternative, antipseudomonal anti-
biotic regimens may need to be considered [26].
Although it has not been tested in our study, procal-
citonin (PCT) is an important biomarker worth to dis-
cuss in this issue. PCT was found very useful to assessthe severity of respiratory disease and the necessity of
antibiotic use as CRP in various studies, and it has been
reported that PCT is a more sensitive marker than CRP.
Cut off values of PCT were recommended between 0,15
ng/ml and 0,5 ng/ml for the best sensitivity and specifi-
city in different studies [27,28].
A limitation of this study could be considered that
data were not available about prior antibiotic consump-
tion of patients that might have an effect on likelihood
of respiratory flora and sputum culture. Other limita-
tions of the study were the inability of identification of
viral agents and the lack of studying PCT.
Conclusion
In conclusion we beleive that CRP and WBC are good
diagnostic markers especially for patients who do not ex-
pectorate sputum sample. Microbiological investigation
of sputum samples should be done in adequate cases in
order establish a rational antibiotic treatment and avoid
unnecessary drug resistance. History of hospital admis-
sion is important for selection of empiric antibiotics.
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